March 2026
1. GUDMUNDSDOTTIR H, Hernandez-Delima FJ, McDowell BC, Starlinger P, et al
   Diagnostic performance of somatostatin receptor positron emission tomography in preoperative evaluation of pancreatic neuroendocrine tumor lymph node metastases.
   Surgery. 2026;194:110136.
   

   >> Share

   
   
2. BUSSMANN F, Stein M, Meier A, Menz M, et al
   Perioperative real-time glucose assessment as a predictive tool for complications after pancreatic resection in nondiabetic patients: A prospective single-center pilot study.
   Surgery. 2026;193:110118.
   

   >> Share

   
   
3. HOUSE MG
   Commentary on "Neoadjuvant therapy versus upfront surgery for resectable pancreatic cancer: updated systematic review, individual-patient-data meta-analysis and trial sequential analysis of randomised controlled trials".
   Surgery. 2026 Mar 6:110124. doi: 10.1016/j.surg.2026.110124.
   

   >> Share

   
   
4. ALIZAI Q, Chatzipanagiotou OP, Mevawalla A, Angez M, et al
   Trends and predictors of hospital charges in liver and pancreatic surgery: A comparative analysis of open, laparoscopic, and robotic approaches.
   Surgery. 2026;193:110121.
   

   >> Share

   
   February 2026
5. PARK Y, Hwang DW, Lee JH, Song KB, et al
   Clinical outcomes of completing total pancreatectomy for isolated recurrence of pancreatic ductal adenocarcinoma in the remnant pancreas after initial pancreatectomy.
   Surgery. 2026;192:110088.
   

   >> Share

   
   
6. VARGHESE C, Choudhary A, Starlinger P, Kendrick M, et al
   Dynamic prediction of early discharge after major pancreatic surgery: Derivation and cross-validation of an automatable electronic medical record-based model.
   Surgery. 2026 Feb 9:109976. doi: 10.1016/j.surg.2025.109976.
   

   >> Share

   
   December 2025
7. TAN HL, Zhao Y, Chua DW, Ng KYY, et al
   Neoadjuvant therapy versus upfront surgery for resectable pancreatic cancer: Updated systematic review, individual-patient-data meta-analysis and trial sequential analysis of randomized controlled trials.
   Surgery. 2025 Dec 10:109872. doi: 10.1016/j.surg.2025.109872.
   

   >> Share

   
   
8. CORVINO G, Marchetti A, Esposito A, Morandi A, et al
   Pancreatic stump perfusion assessment using indocyanine green fluorescence and its impact on postoperative pancreatic fistula: A systematic review and meta-analysis.
   Surgery. 2025;190:109931.
   

   >> Share

   
   
9. KUMAR P, Wehrle CJ, Gross A, Nadeem MA, et al
   The significance of radiologic main duct dilatation in pancreatic intraductal papillary mucinous neoplasms.
   Surgery. 2025 Dec 4:109921. doi: 10.1016/j.surg.2025.109921.
   

   >> Share

   
   
10. SATO A, Anazawa T, Nagai K, Kasai Y, et al
    Optimal strategies for surgical resection of pancreatic body cancer: A multi-institutional cohort study.
    Surgery. 2025;190:109930.
    

    >> Share

    
    November 2025
11. AKITA H, Kobayashi S, Yamada D, Tomimaru Y, et al
    Prognostic significance of neoadjuvant gemcitabine and S-1 chemotherapy with or without concurrent radiation in patients with resectable and borderline resectable pancreatic cancer: A post hoc analysis of 2 phase II trials.
    Surgery. 2025;190:109864.
    

    >> Share

    
    
12. MATTI J, Theivendrampillai T, Soonawalla Z, Hughes D, et al
    Does preoperative prophylactic pancreatic duct stenting prior to enucleation mitigate the risk of postoperative fistula: A meta-analysis.
    Surgery. 2025;190:109856.
    

    >> Share

    
    
13. BATTISTELLA A, Prato F, Andreasi V, Rella R, et al
    Preoperative predictors of new-onset diabetes mellitus following distal pancreatectomy for nonfunctioning pancreatic neuroendocrine tumors.
    Surgery. 2025;190:109866.
    

    >> Share

    
    October 2025
14. JUDISH M, Cannas S, Casciani F, Chopra A, et al
    A risk-adjusted evaluation of the impact of neoadjuvant therapy on pancreatic fistula development after pancreatoduodenectomy.
    Surgery. 2025 Oct 16:109819. doi: 10.1016/j.surg.2025.109819.
    

    >> Share

    
    
15. MAEKAWA A, Oba A, Mie T, Sawa Y, et al
    Exploring the role of CA 19-9 dynamics in pancreatic cancer multidisciplinary treatment: Proposal of the PANC classification.
    Surgery. 2025;188:109783.
    

    >> Share

    
    
16. NOLL J, Roosen H, Fritzenwanker M, Amati AL, et al
    Perioperative multidrug-resistant bacteria impair clinical outcome after pancreatic surgery: Missed targets of antibiotic prophylaxis.
    Surgery. 2025;188:109717.
    

    >> Share

    
    September 2025
17. BECHTIGER FA, Niessen A, Hinz U, Lewosinska M, et al
    Indications and outcome of surgery for small nonfunctioning pancreatic neuroendocrine neoplasms (
    Surgery. 2025;188:109730.
    

    >> Share

    
    
18. LEWELLEN KA, Kim RC, Maatman TK, McGuire SP, et al
    Distal pancreatectomy for chronic pancreatitis: The influence of body mass index.
    Surgery. 2025;188:109722.
    

    >> Share

    
    
19. ZYROMSKI NJ
    Invited editorial regarding "Predicting textbook outcome after pancreaticoduodenectomy for invasive intraductal papillary mucinous neoplasm: An international validation cohort study".
    Surgery. 2025 Sep 13:109731. doi: 10.1016/j.surg.2025.109731.
    

    >> Share

    
    
20. LEONHARDT CS, Narbekovas K, Qadan M, Sahora K, et al
    Prognostic factors for very early recurrence after neoadjuvant treatment and curative resection in pancreatic ductal adenocarcinoma.
    Surgery. 2025;187:109647.
    

    >> Share

    
    August 2025
21. ZHANG Z, Zhao X, Zhu H, Jin L, et al
    Predicting textbook outcome after pancreaticoduodenectomy for invasive intraductal papillary mucinous neoplasm: An international validation cohort study.
    Surgery. 2025 Aug 29:109656. doi: 10.1016/j.surg.2025.109656.
    

    >> Share

    
    
22. CAMPBELL BA, Habib JR, Kinny-Koster B, Purchla J, et al
    The impact of perioperative chemotherapy in patients with pancreatic adenosquamous carcinoma.
    Surgery. 2025;187:109611.
    

    >> Share

    
    
23. TAMBURRINO D, Guarneri G, Provinciali L, Vanella G, et al
    Multidrug-resistant bacterial colonization affects postoperative outcomes after pancreaticoduodenectomy.
    Surgery. 2025;186:109594.
    

    >> Share

    
    
24. SEKI Y, Ishizawa T, Mitsuhashi K, Inagaki NF, et al
    Mechanisms of histopathologic vascular damage caused by pancreatic juice leakage: Implications for preventing hemorrhagic complications.
    Surgery. 2025;186:109591.
    

    >> Share

    
    July 2025
25. LANCELLOTTI F
    Response to Letter to the editor: "The role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-derived parameters as prognostic factors in patients undergoing resection for pancreatic ductal adenocarcinoma".
    Surgery. 2025 Jul 17:109551. doi: 10.1016/j.surg.2025.109551.
    

    >> Share

    
    
26. RAJAONARISON H, Regenet N, Dokmak S, Truant S, et al
    Management of refractory chyle leak after pancreatic surgery: Results from a French national survey on practices and a multicentric study on therapeutic lymphangiography.
    Surgery. 2025;186:109541.
    

    >> Share

    
    
27. MCKEAN JA, Hamilton JS, Tushoski-Aleman G, Thompson G, et al
    Cumulative sum analysis after the initial learning curve for laparoscopic pancreaticoduodenectomy: Does one continue to learn?
    Surgery. 2025;186:109543.
    

    >> Share

    
    June 2025
28. YAMAMOTO Y, Sugiura T, Esaki M, Takahashi Y, et al
    Author's Reply to the Letter regarding our manuscript: "Impact of biliary drainage method before pancreaticoduodenectomy on short- and long-term outcomes in patients with periampullary carcinoma and obstructive jaundice: A multicenter retrospective an
    Surgery. 2025 Jun 19:109486. doi: 10.1016/j.surg.2025.109486.
    

    >> Share

    
    
29. TAN HL, Zhao Y, Chua DW, Teo JY, et al
    Validation and modification of the PAncreatic surgery Composite Endpoint (PACE) model: A single-institution study from Southeast Asia.
    Surgery. 2025;184:109482.
    

    >> Share

    
    
30. SERVIN-ROJAS M, Fernandez-Del Castillo C, Mohamed M, Narayan RR, et al
    Serum carbohydrate antigen 19-9 greater than 100 and risk of invasive carcinoma in pancreatic intraductal papillary mucinous neoplasms: Worrisome feature or high-risk stigmata?
    Surgery. 2025;185:109481.
    

    >> Share

    
    
31. XU Q, Gao Y
    Letter to the editor on "Navigating the learning curve of robotic pancreatoduodenectomy: Competency, proficiency, and mastery in a first-generation robotic surgeon with established open pancreatic expertise".
    Surgery. 2025 Jun 2:109464. doi: 10.1016/j.surg.2025.109464.
    

    >> Share

    
    
32. ZHENG B, Xiao C
    Letter to the editor regarding: "Oncological outcomes of palliative minimally invasive distal pancreatectomy for unexpected metastatic pancreatic ductal adenocarcinoma: A single-center experience".
    Surgery. 2025 Jun 2:109434. doi: 10.1016/j.surg.2025.109434.
    

    >> Share

    
    
33. KATO T, Murase Y, Baba Y, Takase K, et al
    Impact of dynamic risk stratification for postoperative pancreatic fistula using serum pancreatic amylase on the day after pancreatoduodenectomy.
    Surgery. 2025;184:109454.
    

    >> Share

    
    May 2025
34. NEPAL B, Gupta R, Yadav TD, Sahni N, et al
    Semisupervised home-based prehabilitation in patients undergoing pancreaticoduodenectomy: Impact on postoperative outcomes.
    Surgery. 2025;184:109455.
    

    >> Share

    
    
35. AGHAMALIYEV U, Werner J
    Hyperlipasemia in the immediate postoperative period predicts postoperative pancreatic fistula after pancreatic resections.
    Surgery. 2025 May 28:109433. doi: 10.1016/j.surg.2025.109433.
    

    >> Share

    
    
36. MUGHAL SA, Advani A
    Letter to the editor: "The role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-derived parameters as prognostic factors in patients undergoing resection for pancreatic ductal adenocarcinoma".
    Surgery. 2025 May 28:109438. doi: 10.1016/j.surg.2025.109438.
    

    >> Share

    
    
37. HEO D, Cardoso SA, Cardoso RP, Ibrahim NESE, et al
    Clinical implications of postoperative hyperamylasemia and postpancreatectomy acute pancreatitis after pancreatectomy: A systematic review and meta-analysis.
    Surgery. 2025;184:109443.
    

    >> Share

    
    
38. ZHOU X, Xie S
    Postoperative hyperlipasemia and pancreatic fistula risk: A critical reappraisal of diagnostic criteria and cohort heterogeneity.
    Surgery. 2025 May 20:109399. doi: 10.1016/j.surg.2025.109399.
    

    >> Share

    
    
39. YANG F, Xu Y, Jin C, He H, et al
    Periarterial divestment for borderline and locally advanced pancreatic cancer: An analysis of 125 cases in a single center.
    Surgery. 2025;184:109412.
    

    >> Share

    
    
40. NIU W, Zhang Y, Wu J
    Letter to the editor on "Prognostic relevance of lymph node metastasis in pancreaticoduodenectomy for distal cholangiocarcinoma: Rational extent and number-based nodal classification for regional lymphadenectomy".
    Surgery. 2025 May 14:109341. doi: 10.1016/j.surg.2025.109341.
    

    >> Share

    
    
41. HIROSE Y, Sakata J, Nomura T, Takano K, et al
    Response to letter to the editor on: "Prognostic relevance of lymph node metastasis in pancreaticoduodenectomy for distal cholangiocarcinoma: Rational extent and number-based nodal classification for regional lymphadenectomy".
    Surgery. 2025 May 14:109400. doi: 10.1016/j.surg.2025.109400.
    

    >> Share

    
    
42. VALERA RJ, Hossain MS, Patnaik R, Valdivieso C, et al
    Retrospective analysis of surgical pancreatic necrosectomy outcomes in patients with and without obesity.
    Surgery. 2025;184:109410.
    

    >> Share

    
    
43. ZHU S, Ning C, Sun Z, Liu B, et al
    Minimal access retroperitoneal pancreatic necrosectomy for infected pancreatic necrosis: A single-center of 15 years' experience.
    Surgery. 2025;183:109392.
    

    >> Share

    
    
44. DOKMAK S, Karam E, Aussilhou B, Loh WL, et al
    Laparoscopic compared with open pancreatoduodenectomy is safe for the treatment of pancreatic ductal adenocarcinoma treated by chemoradiotherapy.
    Surgery. 2025;181:109281.
    

    >> Share

    
    April 2025
45. ZHANG J, Chen X
    Letter to the editor on "Impact of biliary drainage method before pancreaticoduodenectomy on short- and long-term outcomes in patients with periampullary carcinoma and obstructive jaundice: A multicenter retrospective analysis".
    Surgery. 2025 Apr 29:109380. doi: 10.1016/j.surg.2025.109380.
    

    >> Share

    
    
46. TURNER KM, Ahmad SA
    Large language models as clinical decision support tools: A call for careful implementation in the care of patients with pancreatic cancer.
    Surgery. 2025 Apr 25:109378. doi: 10.1016/j.surg.2025.109378.
    

    >> Share

    
    
47. WALSH RM
    Seeking mastery in robotic pancreaticoduodenectomy: Comment on: "Navigating the learning curve of robotic pancreaticoduodenectomy: Competency, proficiency, and mastery in a first-generation robotic surgeon with established open pancreatic expertise".
    Surgery. 2025 Apr 22:109375. doi: 10.1016/j.surg.2025.109375.
    

    >> Share

    
    
48. DAI Y, Fu J, Lu X, Wang Y, et al
    Differences in grade C postpancreatectomy hemorrhage with or without clinically relevant pancreatic fistula after pancreaticoduodenectomy: A retrospective cohort study.
    Surgery. 2025;183:109355.
    

    >> Share

    
    
49. HUANG Y, Lin J
    Comment on: "Recurrence and treatment trends of pancreatic neuroendocrine tumors".
    Surgery. 2025 Apr 7:109349. doi: 10.1016/j.surg.2025.109349.
    

    >> Share

    
    
50. NAPOLI N, Ginesini M, Kauffmann EF, Barbarello L, et al
    Navigating the learning curve of robotic pancreatoduodenectomy: Competency, proficiency, and mastery in a first-generation robotic surgeon with established open pancreatic expertise.
    Surgery. 2025 Apr 2:109347. doi: 10.1016/j.surg.2025.109347.
    

    >> Share

    
    March 2025
51. PARK Y, Hwang DW, Lee JH, Song KB, et al
    Oncological outcomes of palliative minimally invasive distal pancreatectomy for unexpected metastatic pancreatic ductal adenocarcinoma: A single-center experience.
    Surgery. 2025;182:109331.
    

    >> Share

    
    
52. DUHN J, von Fritsch L, Bolm L, Braun R, et al
    Perioperative and oncologic outcomes after total pancreatectomy and pancreatoduodenectomy for pancreatic head adenocarcinoma-A propensity score-matched analysis from the German Cancer Registry Group.
    Surgery. 2025;181:109292.
    

    >> Share

    
    
53. AJAZ M
    Postoperative prophylactic antibiotic therapy after pancreaticoduodenectomy in bile duct-stented patients reduces postoperative major complications.
    Surgery. 2025 Mar 14:109320. doi: 10.1016/j.surg.2025.109320.
    

    >> Share

    
    
54. LANCELLOTTI F, Patel A, Tsaramanidis S, Edy E, et al
    The role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-derived parameters as prognostic factors in patients undergoing resection for pancreatic ductal adenocarcinoma.
    Surgery. 2025;181:109271.
    

    >> Share

    
    
55. KAISER KN, Hughes AJ, Yang AD, Mohanty S, et al
    Use of large language models as clinical decision support tools for management pancreatic adenocarcinoma using National Comprehensive Cancer Network guidelines.
    Surgery. 2025 Mar 6:109267. doi: 10.1016/j.surg.2025.109267.
    

    >> Share

    
    
56. CAPRETTI G, Ricci C, Langella S, Nicolini D, et al
    Outcomes after pancreatoduodenectomy and total pancreatectomy in patients with a high-risk pancreatic anastomosis: An entropy balance analysis.
    Surgery. 2025;181:109277.
    

    >> Share

    
    
57. PITAKTEERABUNDIT T, Fagenholz PJ, Luckhurst CM, Albutt KH, et al
    Response to letter to the editor on "Acute pancreatitis in intraductal papillary mucinous neoplasm: Associations with epithelial subtype, degree of dysplasia, and risk of recurrence".
    Surgery. 2025 Mar 3:109276. doi: 10.1016/j.surg.2025.109276.
    

    >> Share

    
    February 2025
58. AGHAMALIYEV U, Werner J
    Response to Letter to the editor: "Hyperlipasemia in the immediate postoperative period predicts postoperative pancreatic fistula after pancreatic resections".
    Surgery. 2025 Feb 15:109208. doi: 10.1016/j.surg.2025.109208.
    

    >> Share

    
    
59. SHI C, Zhang J, Wang W
    Letter to the editor on "Acute pancreatitis in intraductal papillary mucinous neoplasm: Associations with epithelial subtype, degree of dysplasia, and risk of recurrence".
    Surgery. 2025 Feb 15:109213. doi: 10.1016/j.surg.2025.109213.
    

    >> Share

    
    
60. AGHAMALIYEV U, Werner J
    Authors' reply regarding "Hyperlipasemia in the immediate postoperative period predicts postoperative pancreatic fistula after pancreatic resections".
    Surgery. 2025 Feb 15:109216. doi: 10.1016/j.surg.2025.109216.
    

    >> Share

    
    January 2025
61. OCUIN LM
    Response to: Letter to the editor on "Extended antibiotics and clinically relevant postoperative pancreatic fistula in elevated-risk patients: A single institution analysis".
    Surgery. 2025 Jan 25:109148. doi: 10.1016/j.surg.2024.109148.
    

    >> Share

    
    
62. AKITA H, Mukai Y, Kubo M, Wada H, et al
    Reply to letter to editor by yinfang Wu, MM about our manuscript, "A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable or borderline resectable pancreatic cancer".
    Surgery. 2025 Jan 25:109132. doi: 10.1016/j.surg.2024.109132.
    

    >> Share

    
    
63. MARCHEGIANI G
    Reading the tea leaves: Acute pancreatitis as a red flag in intraductal papillary mucinous neoplasms of the pancreas.
    Surgery. 2025 Jan 24:109140. doi: 10.1016/j.surg.2024.109140.
    

    >> Share

    
    
64. YE W, Dong D, Shi X
    Letter to the editor on "Laparoscopic pancreatoduodenectomy is safe for the treatment of pancreatic ductal adenocarcinoma treated by chemoradiotherapy compared with open pancreatoduodenectomy: A matched case-control study".
    Surgery. 2025 Jan 21:109135. doi: 10.1016/j.surg.2024.109135.
    

    >> Share

    
    
65. HUANG S, Huang Y
    Comment on: "Hyperlipasemia in the immediate postoperative period predicts postoperative pancreatic fistula after pancreatic resections".
    Surgery. 2025 Jan 18:109054. doi: 10.1016/j.surg.2024.109054.
    

    >> Share

    
    
66. CETINKAYA E
    Letter to the editor regarding "Laparoscopic pancreatoduodenectomy is safe for the treatment of pancreatic ductal adenocarcinoma treated by chemoradiotherapy compared with open pancreatoduodenectomy: A matched case-control study".
    Surgery. 2025 Jan 18:109130. doi: 10.1016/j.surg.2024.109130.
    

    >> Share

    
    
67. HIROSE Y, Sakata J, Nomura T, Takano K, et al
    Prognostic relevance of lymph node metastasis in pancreaticoduodenectomy for distal cholangiocarcinoma: Rational extent and number-based nodal classification for regional lymphadenectomy.
    Surgery. 2025;180:109099.
    

    >> Share

    
    
68. SCHORN S, Fritz A, Kaissis G, Gaida MM, et al
    Neural invasion severity is a strong predictor of local recurrence in pancreatic ductal adenocarcinoma.
    Surgery. 2025;180:109018.
    

    >> Share

    
    
69. ROMPEN IF, Marchetti A, Levine J, Swett B, et al
    Impact of resection margin status on recurrence and survival in patients with resectable, borderline resectable, and locally advanced pancreatic cancer.
    Surgery. 2025;180:109114.
    

    >> Share

    
    
70. FU Z, Qin J, Zheng K, Liu X, et al
    Periarterial divestment following neoadjuvant therapy in patients with locally advanced pancreatic cancer with celiac axis invasion: A safe and effective surgical procedure.
    Surgery. 2025;180:109045.
    

    >> Share

    
    
71. DEI H, Yokoyama Y, Mizuno T, Asahara T, et al
    Impact of the ratio of fecal short-chain fatty acids to lactic acid concentration on postoperative infectious complications after pancreaticoduodenectomy.
    Surgery. 2025;180:109040.
    

    >> Share

    
    
72. AKITA H, Mukai Y, Kubo M, Wada H, et al
    Response to letter to the editor: "A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable or borderline resectable pancreatic cancer".
    Surgery. 2025 Jan 3:109053. doi: 10.1016/j.surg.2024.109053.
    

    >> Share

    
    December 2024
73. PITAKTEERABUNDIT T, Fagenholz PJ, Luckhurst CM, Albutt KH, et al
    Acute pancreatitis in intraductal papillary mucinous neoplasm: Associations with epithelial subtype, degree of dysplasia, and risk of recurrence.
    Surgery. 2024 Dec 31:109038. doi: 10.1016/j.surg.2024.109038.
    

    >> Share

    
    
74. MURASE Y, Esaki M, Mizui T, Takamoto T, et al
    Optimal lymph node dissection area for pancreatic neuroendocrine neoplasms by tumor location, size, and grade.
    Surgery. 2024;180:109029.
    

    >> Share

    
    
75. TAKAMOTO T, Nara S, Ban D, Mizui T, et al
    Neoadjuvant gemcitabine and S-1 in pancreatic ductal adenocarcinoma: Effects on nutritional status and pancreaticoduodenectomy outcomes.
    Surgery. 2024;180:109026.
    

    >> Share

    
    
76. ZHU J
    Letter to the editor on "Extended antibiotic therapy is associated with a lower rate of clinically relevant postoperative pancreatic fistula after pancreatoduodenectomy (PD) in intermediate- and high-risk patients: A single-institution analysis".
    Surgery. 2024 Dec 27:109010. doi: 10.1016/j.surg.2024.109010.
    

    >> Share

    
    
77. WANG C, Tian H, Shang J
    Exploration and perspectives on postoperative hyperlipasemia as a predictor of pancreatic fistula.
    Surgery. 2024 Dec 27:109025. doi: 10.1016/j.surg.2024.109025.
    

    >> Share

    
    
78. AKITA H, Mukai Y, Kubo M, Wada H, et al
    Reply to letter to editor by Duo Yun, MD regarding our article, "A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable or borderline resectable pancreatic cancer".
    Surgery. 2024 Dec 20:108952. doi: 10.1016/j.surg.2024.
    

    >> Share

    
    
79. PENG L, Cao B, Wu Y
    Letter to the editor: "A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable and borderline resectable pancreatic cancer".
    Surgery. 2024 Dec 11:108962. doi: 10.1016/j.surg.2024.108962.
    

    >> Share

    
    
80. DADHWAL US
    Letter to the editor: Postoperative prophylactic antibiotic therapy after pancreaticoduodenectomy in bile duct-stented patients reduces postoperative major complications.
    Surgery. 2024 Dec 11:108961. doi: 10.1016/j.surg.2024.108961.
    

    >> Share

    
    
81. IKENAGA N, Nakata K, Abe T, Watanabe Y, et al
    Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma.
    Surgery. 2024;178:108958.
    

    >> Share

    
    
82. WU YF, Zhao Q
    Letter to the editor: "A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable and borderline resectable pancreatic cancer".
    Surgery. 2024 Dec 8:108963. doi: 10.1016/j.surg.2024.108963.
    

    >> Share

    
    
83. SHIBAMOTO J, Ohgi K, Ashida R, Yamada M, et al
    Clinical significance of resection and adjuvant chemotherapy for pancreatic ductal adenocarcinoma with occult para-aortic lymph node metastasis.
    Surgery. 2024 Dec 1:108925. doi: 10.1016/j.surg.2024.
    

    >> Share

    
    November 2024
84. PIPER TB, Schaebel GH, Egeland C, Achiam MP, et al
    Fluorescence-guided pancreatic surgery: A scoping review.
    Surgery. 2024 Nov 28:108931. doi: 10.1016/j.surg.2024.
    

    >> Share

    
    
85. NOMURA S, Masui T, Muto J, Hashida K, et al
    Is distal pancreatectomy the optimal surgical procedure for pancreatic neck cancer?
    Surgery. 2024 Nov 23:108930. doi: 10.1016/j.surg.2024.
    

    >> Share

    
    
86. TSILIMIGRAS DI, Pawlik TM
    Response to letter to the editor on "Long-term lorazepam use may be associated with worse long-term outcomes among patients with pancreatic adenocarcinoma".
    Surgery. 2024 Nov 22:108915. doi: 10.1016/j.surg.2024.
    

    >> Share

    
    
87. KONG Y, Yang Y, Song A, Wang X, et al
    Letter to the editor on "Long-term lorazepam use may be associated with worse long-term outcomes among patients with pancreatic adenocarcinoma".
    Surgery. 2024 Nov 8:S0039-6060(24)00883-3. doi: 10.1016/j.surg.2024.
    

    >> Share

    
    
88. KARAM E, Ronde-Roupie C, Aussilhou B, Hentic O, et al
    Laparoscopic pancreatoduodenectomy is safe for the treatment of pancreatic ductal adenocarcinoma treated by chemoradiotherapy compared with open pancreatoduodenectomy: A matched case-control study.
    Surgery. 2024 Nov 1:S0039-6060(24)00829-8. doi: 10.1016/j.surg.2024.
    

    >> Share

    
    October 2024
89. KAIDA H, Miyasaka Y, Higashi D, Yamamoto R, et al
    Clinical significance of intraductal papillary mucinous neoplasms incidentally detected in patients with extrapancreatic gastrointestinal malignancies with a focus on pancreatic cancer development.
    Surgery. 2024 Oct 30:S0039-6060(24)00840-7. doi: 10.1016/j.surg.2024.
    

    >> Share

    
    
90. YUN D
    Letter to the editor regarding "A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable and borderline resectable pancreatic cancer".
    Surgery. 2024 Oct 12:S0039-6060(24)00772-4. doi: 10.1016/j.surg.2024.
    

    >> Share

    
    
91. KATO T, Watanabe Y, Baba Y, Oshima Y, et al
    Preoperative risk-stratified analysis: External versus internal pancreatic stents in pancreatoduodenectomy.
    Surgery. 2024 Oct 8:S0039-6060(24)00715-3. doi: 10.1016/j.surg.2024.
    

    >> Share

    
    
92. AGHAMALIYEV U, Cepele G, Hofmann FO, Knoblauch M, et al
    Hyperlipasemia in the immediate postoperative period predicts postoperative pancreatic fistula after pancreatic resections.
    Surgery. 2024 Oct 6:S0039-6060(24)00700-1. doi: 10.1016/j.surg.2024.
    

    >> Share

    
    
93. GREENSPUN BC, Foshag A, Tumati A, Marshall T, et al
    DAXX is associated with early recurrence of pancreatic neuroendocrine tumors after R0 resection.
    Surgery. 2024 Oct 4:S0039-6060(24)00694-9. doi: 10.1016/j.surg.2024.
    

    >> Share

    
    
94. BADER A, Landau S, Hwang J, Passman J, et al
    Recurrence and treatment trends of pancreatic neuroendocrine tumors.
    Surgery. 2024 Oct 4:S0039-6060(24)00703-7. doi: 10.1016/j.surg.2024.
    

    >> Share

    
    September 2024
95. LIM JS, Lozano V, Heard J, Malo J, et al
    Redefining at-risk patients undergoiong pancreaticoduodenectomy: Impact of socioeconomic factors including Area Deprivation Index and distance traveled.
    Surgery. 2024 Sep 25:S0039-6060(24)00651-2. doi: 10.1016/j.surg.2024.
    

    >> Share

    
    
96. TSILIMIGRAS DI, Woldesenbet S, Chatzipanagiotou OP, Iyer S, et al
    Long-term lorazepam use may be associated with worse long-term outcomes among patients with pancreatic adenocarcinoma.
    Surgery. 2024 Sep 19:S0039-6060(24)00641-X. doi: 10.1016/j.surg.2024.
    

    >> Share

    
    August 2024
97. ZOU Y, Xie Y, Huang J, Liang Y, et al
    Survival outcomes of adjuvant chemotherapy in patients with stage I pancreatic cancer stratified by pathologic risk.
    Surgery. 2024 Aug 26:S0039-6060(24)00566-X. doi: 10.1016/j.surg.2024.
    

    >> Share

    
    
98. TAMBURRINO D, Arcangeli C, De Stefano F, Belfiori G, et al
    Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrence.
    Surgery. 2024 Aug 26:S0039-6060(24)00544-0. doi: 10.1016/j.surg.2024.
    

    >> Share

    
    
99. HUANG Y
    Letter to the editor regarding: "Meta-analysis of adjuvant chemotherapy versus no adjuvant chemotherapy for resected stage I pancreatic cancer".
    Surgery. 2024 Aug 20:S0039-6060(24)00556-7. doi: 10.1016/j.surg.2024.
    

    >> Share

    
    
100. PARTELLI S, Pecorelli N
     Time to close the gap between surgical success and recovery after pancreaticoduodenectomy.
     Surgery. 2024 Aug 15:S0039-6060(24)00495-1. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     July 2024
101. AKITA H, Mukai Y, Kubo M, Takahashi H, et al
     A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable and borderline resectable pancreatic cancer.
     Surgery. 2024 Jul 29:S0039-6060(24)00473-2. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     
102. LI Z, Zhou L, Li M, Wang W, et al
     Early mobilization after pancreatic surgery: A randomized controlled trial.
     Surgery. 2024 Jul 24:S0039-6060(24)00450-1. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     
103. ICHIDA H, Imamura H, Takahashi A, Yoshioka R, et al
     Evaluation of pancreatic morphometric parameters, exocrine function, and nutritional status and their causal relationships in long-term survivors following pancreatectomy.
     Surgery. 2024 Jul 12:S0039-6060(24)00377-5. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     
104. ELLIS RJ
     Invited Commentary for "Postoperative prophylactic antibiotic therapy after pancreaticoduodenectomy in bile duct-stented patients reduces postoperative major complications".
     Surgery. 2024 Jul 11:S0039-6060(24)00452-5. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     
105. LE NK, Chervu NL, Ng A, Gao Z, et al
     Center-level variation in hospitalization costs of pancreaticoduodenectomy for pancreatic cancer.
     Surgery. 2024 Jul 5:S0039-6060(24)00369-6. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     
106. OCUIN LM, Hardacre JM
     Extended antibiotics and clinically relevant postoperative pancreatic fistula in elevated-risk patients: A letter in response to "Hidden determinants of the duration of antibiotics after pancreaticoduodenectomy".
     Surgery. 2024 Jul 4:S0039-6060(24)00382-9. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     June 2024
107. BASSI C, Marchegiani G, Dervenis C, Sarr M, et al
     Corrigendum to "The 2016 update of the International Study Group (ISGPF) definition and grading of postoperative pancreatic fistula: eleven years after." Surgery 2017. Mar; 161 (3):584-591. Epub Dec 28, 2016.
     Surgery. 2024 Jun 25:S0039-6060(24)00374-X. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     
108. YAMAMOTO Y, Sugiura T, Esaki M, Takahashi Y, et al
     Impact of biliary drainage method before pancreaticoduodenectomy on short- and long-term outcomes in patients with periampullary carcinoma and obstructive jaundice: A multicenter retrospective analysis.
     Surgery. 2024 Jun 21:S0039-6060(24)00308-8. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     
109. MUNIR MM, Rashid Z, Endo Y, Dillhoff M, et al
     Association between quality metric adherence and overall survival among patients undergoing resection of pancreatic ductal adenocarcinoma.
     Surgery. 2024 Jun 17:S0039-6060(24)00309-X. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     
110. KATO T, Watanabe Y, Oshima Y, Takase K, et al
     Long-term outcomes and risk factors of pancreatic insufficiency after a pancreatoduodenectomy: A retrospective study.
     Surgery. 2024 Jun 14:S0039-6060(24)00298-8. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     May 2024
111. ADDEO P, de Mathelin P, Doussot A, Durin T, et al
     Minimally invasive versus open distal pancreatectomy for resectable pancreatic neuroendocrine tumors: A propensity score matched multicentric comparative French study.
     Surgery. 2024 May 25:S0039-6060(24)00229-0. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     
112. HARRISON J, Dua MM, Kastrinakis WV, Fagenholz PJ, et al
     "Duct tape:" Management strategies for the pancreatic anastomosis during pancreatoduodenectomy.
     Surgery. 2024 May 24:S0039-6060(24)00270-8. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     
113. PETROVA E, Mazzella E, Wellner U, Keck T, et al
     Monopolar electrocautery versus scalpel for pancreatic neck transection during open pancreatoduodenectomy: A retrospective, registry-based study.
     Surgery. 2024 May 23:S0039-6060(24)00188-0. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     
114. STEFFANI M, Jager C, Huser N, Friess H, et al
     Postoperative prophylactic antibiotic therapy after pancreaticoduodenectomy in bile duct-stented patients reduces postoperative major complications.
     Surgery. 2024 May 19:S0039-6060(24)00190-9. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     
115. YANG Y, Li Z, Du Z
     Letter to the editor on "The risk of clinically-relevant pancreatic fistula after pancreaticoduodenectomy is better predicted by a postoperative trend in drain fluid amylase compared to day 1 values in isolation".
     Surgery. 2024 May 16:S0039-6060(24)00183-1. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     
116. MARIQUE L, Codjia T, Dembinski J, Dokmak S, et al
     Retromesenteric omental flap as arterial coverage in pancreaticoduodenectomy: A novel technique to prevent postpancreatectomy hemorrhage.
     Surgery. 2024 May 16:S0039-6060(24)00204-6. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     
117. MIZUNO Y, Yokoyama Y, Nakajima H, Inoue T, et al
     The impact of goal-directed prehabilitation therapy on functional capacity in patients undergoing hepatobiliary and pancreatic surgery: A randomized clinical trial.
     Surgery. 2024 May 15:S0039-6060(24)00272-1. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     
118. HUGHES DLL, Hughes A, Gordon-Weeks AN, Silva MA, et al
     Continuous drain irrigation as a risk mitigation strategy for postoperative pancreatic fistula: a meta-analysis.
     Surgery. 2024 May 10:S0039-6060(24)00192-2. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     
119. ITO H
     Hidden determinants of the duration of antibiotics after pancreaticoduodenectomy.
     Surgery. 2024 May 7:S0039-6060(24)00182-X. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     April 2024
120. HOUSE MG
     Invited commentary for "Meta-analysis of adjuvant chemotherapy versus no adjuvant chemotherapy for resected stage I pancreatic cancer.
     Surgery. 2024 Apr 15:S0039-6060(24)00147-8. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     
121. MANZELLA A, Ecker BL, Eskander MF, Grandhi MS, et al
     Operative trends for pancreatic and hepatic malignancies during the COVID-19 pandemic.
     Surgery. 2024 Apr 6:S0039-6060(24)00125-9. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     March 2024
122. SRIENC MK, Donahue TR
     Carnitine palmitoyltransferase 1B mediates gemcitabine resistance in pancreatic cancer.
     Surgery. 2024 Mar 25:S0039-6060(24)00116-8. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     
123. MAEHIRA H, Tani M, Mori H, Ichikawa D, et al
     Long-term outcomes after spleen-preserving distal pancreatectomy with splenic vessels preservation or resection: A nationwide survey of the Japanese Society of Pancreatic Surgery.
     Surgery. 2024 Mar 21:S0039-6060(24)00053-9. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     
124. WISMANS LV, Suurmeijer JA, van Dongen JC, Bonsing BA, et al
     Preoperative chemoradiotherapy but not chemotherapy is associated with reduced risk of postoperative pancreatic fistula after pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a nationwide analysis.
     Surgery. 2024 Mar 5:S0039-6060(24)00055-2. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     February 2024
125. WARD EP, Vincent-Sheldon S, Tolat P, Kulkarni N, et al
     Median arcuate ligament release at the time of pancreaticoduodenectomy or total pancreatectomy.
     Surgery. 2024 Feb 26:S0039-6060(24)00041-2. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     
126. NING C, Sun Z, Shen D, Lin C, et al
     Is Contemporary Open Pancreatic Necrosectomy Still Useful In The Minimally Invasive Era?
     Surgery. 2024 Feb 19:S0039-6060(24)00046-1. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     
127. SHIMIZU T, Maeda S, Link J, Deranteriassian A, et al
     Clinical and pathological factors associated with survival in patients with pancreatic cancer who receive adjuvant therapy after neoadjuvant therapy: A retrospective multi-institutional analysis.
     Surgery. 2024 Feb 15:S0039-6060(24)00008-4. doi: 10.1016/j.surg.2024.
     

     >> Share

     
     
128. STAUFFER JA, Hyman D, Porrazzo G, Tice M, et al
     A propensity score-matched analysis of laparoscopic versus open pancreaticoduodenectomy: Is there value to a laparoscopic approach?
     Surgery. 2024 Feb 1:S0039-6060(23)00965-0. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     
129. FARAH E, Al Abbas A, Abreu AA, Cheng M, et al
     Minimally invasive pancreaticoduodenectomy: A favorable approach for frail patients with pancreatic cancer.
     Surgery. 2024 Feb 1:S0039-6060(23)00966-2. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     January 2024
130. TUERHONG A, Xu J, Wang W, Shi S, et al
     CPT1B maintains redox homeostasis and inhibits ferroptosis to induce gemcitabine resistance via the KEAP1/NRF2 axis in pancreatic cancer.
     Surgery. 2024 Jan 31:S0039-6060(23)00963-7. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     
131. FU Z, Gao S, Wu X, Qin J, et al
     Hand-sewn gastrojejunal anastomosis reduces delayed gastric emptying after pancreaticoduodenectomy: A single-center retrospective clinical study of 1,077 consecutive patients.
     Surgery. 2024 Jan 29:S0039-6060(23)00905-4. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     
132. ATYAH MM, Huang J, Yang Z
     Intraoperative segmental pancreatic occlusion and insulin assay combination optimizes the localization of lesions and confirmation of complete resection in pancreatic hypoglycemia patients.
     Surgery. 2024 Jan 23:S0039-6060(23)00906-6. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     
133. NIESSEN A, Klaiber U, Lewosinska M, Nickel F, et al
     Portal vein resection in pancreatic neuroendocrine neoplasms.
     Surgery. 2024 Jan 22:S0039-6060(23)00964-9. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     December 2023
134. EVANS D, Ghassemi N, Hajibandeh S, Hajibandeh S, et al
     Meta-analysis of adjuvant chemotherapy versus no adjuvant chemotherapy for resected stage I pancreatic cancer.
     Surgery. 2023 Dec 29:S0039-6060(23)00893-0. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     
135. PETRUCH N, Servin Rojas M, Lillemoe KD, Castillo CF, et al
     The impact of surgical-oncologic textbook outcome in patients with stage I to III pancreatic ductal adenocarcinoma: A cross-validation study of two national registries.
     Surgery. 2023 Dec 12:S0039-6060(23)00844-9. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     
136. JEUNE F, Collard M, Augustin J, Guedj N, et al
     Splenic vein tumor thrombosis is a major prognostic factor in distal pancreatic adenocarcinoma.
     Surgery. 2023 Dec 8:S0039-6060(23)00818-8. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     
137. YAMGUCHI T, Mori K, Kojima Y, Hasegawa T, et al
     Efficacy of perioperative oral care management in the prevention of surgical complications in 503 patients after pancreaticoduodenectomy for resectable malignant tumor: A multicenter retrospective analysis using propensity score matching.
     Surgery. 2023 Dec 6:S0039-6060(23)00848-6. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     
138. VON EHRLICH-TREUENSTATT VH, Guenther M, Ilmer M, Knoblauch MM, et al
     Preoperative ultrasound elastography for postoperative pancreatic fistula prediction after pancreatoduodenectomy: A prospective study.
     Surgery. 2023 Dec 2:S0039-6060(23)00828-0. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     November 2023
139. MUADDI H, Salehinejad H, Thiels CA
     Persistent challenges in pancreatic surgery: Postoperative pancreatic fistula prediction in the machine learning era-Response to: Machine learning versus logistic regression for the prediction of complications after pancreaticoduodenectomy.
     Surgery. 2023 Nov 30:S0039-6060(23)00836-X. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     
140. KUBO H, Ohgi K, Ohike N, Norose T, et al
     Tumor vascularity on contrast-enhanced computed tomography as a predictive marker of metastatic potential for small nonfunctioning pancreatic neuroendocrine tumors.
     Surgery. 2023 Nov 29:S0039-6060(23)00809-7. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     
141. SERVIN-ROJAS M, Fong ZV, Fernandez-Del Castillo C, Ferrone CR, et al
     Tumor Size Reduction and Serum Carbohydrate Antigen 19-9 Kinetics After Neoadjuvant FOLFIRINOX in Patients With Pancreatic Ductal Adenocarcinoma.
     Surgery. 2023 Nov 8:S0039-6060(23)00711-0. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     
142. OCUIN LM, Loftus A, Elshami M, Hue JJ, et al
     Extended antibiotic therapy is associated with a lower rate of clinically relevant postoperative pancreatic fistula after pancreatoduodenectomy in intermediate- and high-risk patients: A single-institution analysis.
     Surgery. 2023 Nov 6:S0039-6060(23)00719-5. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     October 2023
143. PARK SS, Verm RA, Abdelsattar ZM, Kramer S, et al
     Fragmented care in localized pancreatic cancer: Is commission on cancer accreditation associated with improved overall survival?
     Surgery. 2023 Oct 18:S0039-6060(23)00608-6. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     
144. STEPHENS K, Philips PP, Egger ME, Scoggins CR, et al
     Multi-institutional review of adverse events associated with irreversible electroporation in the treatment of locally advanced pancreatic cancer.
     Surgery. 2023 Oct 16:S0039-6060(23)00609-8. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     
145. XU Y, Jin C, Fu D, Yang F, et al
     External validation of fistula risk scores for postoperative pancreatic fistula after distal pancreatectomy.
     Surgery. 2023 Oct 10:S0039-6060(23)00588-3. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     September 2023
146. SALVIA R, Burelli A, Nepi A, Caravati A, et al
     Pancreatic cystic neoplasms: Still high rates of preoperative misdiagnosis in the guidelines and endoscopic ultrasound era.
     Surgery. 2023 Sep 25:S0039-6060(23)00444-0. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     July 2023
147. FLEMING AM, Hendrick LE, Glazer ES, Murphy AJ, et al
     Pancreatic carcinosarcoma: An orthogonal analysis.
     Surgery. 2023 Jul 29:S0039-6060(23)00423-3. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     
148. AHMAD SB, Hodges JC, Nassour I, Casciani F, et al
     The risk of clinically-relevant pancreatic fistula after pancreaticoduodenectomy is better predicted by a postoperative trend in drain fluid amylase compared to day 1 values in isolation.
     Surgery. 2023 Jul 17:S0039-6060(23)00392-6. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     
149. GROEN JV, Michiels N, Besselink MG, Bosscha K, et al
     Practice variation in venous resection during pancreatoduodenectomy for pancreatic cancer: A nationwide cohort study.
     Surgery. 2023 Jul 13:S0039-6060(23)00395-1. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     June 2023
150. CAPACIO BA, Shankara Narayanan JS, Vicente DA, Liu Y, et al
     Pressure-Enabled Drug Delivery (PEDD) of a class C TLR9 agonist in combination with checkpoint inhibitor therapy in a murine pancreatic cancer model.
     Surgery. 2023 Jun 28:S0039-6060(23)00306-9. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     
151. STUART CM, Kirsch MJ, Zhuang Y, Meguid CL, et al
     Pulmonary metastasectomy is associated with survival after lung-only recurrence in pancreatic cancer.
     Surgery. 2023 Jun 28:S0039-6060(23)00303-3. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     
152. CHO NY, Chervu NL, Sakowitz S, Verma A, et al
     Effect of surgical timing on outcomes after cholecystectomy for mild gallstone pancreatitis.
     Surgery. 2023 Jun 22:S0039-6060(23)00304-5. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     
153. HONSELMANN KC, Elser Y, Boeckmann T, Bolm L, et al
     Recent onset diabetes is associated with better survival in pancreatic ductal adenocarcinoma-An analysis of preoperative symptoms within the DGAV StuDoQ|Pancreas Registry.
     Surgery. 2023 Jun 20:S0039-6060(23)00248-9. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     
154. ALHULAILI ZM, Linnemann RJ, Dascau L, Pleijhuis RG, et al
     A Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis analysis to evaluate the quality of reporting of postoperative pancreatic fistula prediction models after pancreatoduodenectomy: A systematic review.
     Surgery. 2023 Jun 7:S0039-6060(23)00264-7. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     May 2023
155. KUBO H, Ohgi K, Ohike N, Tone K, et al
     Corrigendum to Clinical significance of immunocytochemical staining for peritoneal lavage cytology in pancreatic cancer: [Surgery. 2022;172(6):1776-81, DOI: 10.1016/j.surg.2022.09.025].
     Surgery. 2023 May 30:S0039-6060(23)00268-4. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     
156. ROY M, Kocher HM
     Pancreatitis sepsis: Evolution and principles in the management of necrotizing pancreatitis.
     Surgery. 2023 May 15:S0039-6060(23)00199-X. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     April 2023
157. KATOU S, Wenning AS, Aeschbacher P, Morgul H, et al
     Resection margin status at the portomesenteric axis may not determine oncologic outcome after pancreaticoduodenectomy for lymph node-positive pancreatic ductal adenocarcinoma.
     Surgery. 2023 Apr 28:S0039-6060(23)00129-0. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     
158. SUGUMAR K, Gendi S, Quereshy HA, Gupta S, et al
     An analysis of time to treatment in patients with pancreatic adenocarcinoma.
     Surgery. 2023 Apr 25:S0039-6060(23)00157-5. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     March 2023
159. MIZUNUMA K, Kurashima Y, Poudel S, Watanabe Y, et al
     Surgical skills assessment of pancreaticojejunostomy using a simulator may predict patient outcomes: A multicenter prospective observational study.
     Surgery. 2023 Mar 30:S0039-6060(23)00116-2. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     
160. BANNONE E, Marchegiani G, Zamboni GA, Maris BM, et al
     Acute pancreatitis after pancreatoduodenectomy: A prospective study of diffusion-weighted magnetic resonance imaging, serum biomarkers, and clinical features.
     Surgery. 2023 Mar 17:S0039-6060(23)00060-0. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     
161. CUCCHETTI A, Djulbegovic B, Crippa S, Hozo I, et al
     Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer.
     Surgery. 2023 Mar 15:S0039-6060(23)00042-9. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     February 2023
162. SUURMEIJER JA, Emmen AM, Bonsing BA, Busch OR, et al
     Nationwide validation of the ISGPS risk classification for postoperative pancreatic fistula after pancreatoduodenectomy: "Less is more".
     Surgery. 2023 Feb 27:S0039-6060(23)00004-1. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     
163. HEWITT DB, Wolfgang CL
     Invited commentary for the article "Evaluation of local recurrence after pancreaticoduodenectomy for borderline resectable pancreatic head cancer with neoadjuvant chemotherapy: Can the resection level change after chemotherapy?".
     Surgery. 2023 Feb 26:S0039-6060(23)00046-6. doi: 10.1016/j.surg.2023.
     

     >> Share

     
     
164. RAZA SS, Nutu A, Powell-Brett S, Marchetti A, et al
     Early postoperative risk stratification in patients with pancreatic fistula after pancreaticoduodenectomy.
     Surgery. 2023;173:492-500.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share